Domov › Sladkorna bolezen tipa 2 › New York
Klinične študije za Sladkorna bolezen tipa 2 v New York
33 študij za Sladkorna bolezen tipa 2 išče udeležence na lokacijah v New York.
Mesta v New York
- New York City16 študij
- Brooklyn7 študij
- The Bronx6 študij
- Syracuse5 študij
- Buffalo5 študij
- Manhattan3 študij
- Cheektowaga3 študij
- Albany3 študij
Uradno besedilo študije (angleško)
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
- State University of New York at Buffalo, South Campus, Buffalo
Vključevanje udeležencev
Starost 18–60 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07641361A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Rochester Clinical Research - Buffalo, Buffalo
- CHEAR Center LLC, The Bronx
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Albany Med Health System - Washington Avenue Extension, Albany
- Velocity Clinical Research - Binghamton, Binghamton
- RCR - Buffalo, Buffalo
- in še 7
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Ellipsis Research Group - Brooklyn, Brooklyn
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Clindove Research, Brooklyn
- Swift Clinical Research, Brooklyn
- Rasaj Research, Jackson Heights
- in še 4
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 55 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Weill Cornell Medicine - Comprehensive Weight Control Center, New York
- Rochester Clinical Research, LLC, Rochester
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07595549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NYC Research INC, Long Island City
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, East Northport
- AURORA-2 Clinical Site, East Syracuse
- AURORA-2 Clinical Site, New Windsor
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450LINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomes
- NYU Langone Health, New York
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT06319716A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Brooklyn Clinical Research, Brooklyn
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07340320A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- NYC Research INC, Long Island City
- Richmond University Medical Center, Staten Island
- Southgate Medical Group, West Seneca
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06897475Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Velocity Clinical Research, Binghamton
- CHEAR Center LLC, The Bronx
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07271186Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Albany Medical College, Albany
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07296484A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- UBMD Pediatrics, Buffalo
- NYU Langone Orthopedic Center, New York
Vključevanje udeležencevFaza 3
Starost 10–18 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07282613Graded Insulin Suppression Test P&F
- Columbia University Irving Medical Center, New York
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06592261Alpelisib Challenge Test (ACT)
- Columbia University Irving Medical Center, New York
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–70 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07778524A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, The Bronx
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Central New York Clinical Research CNYCR, Manlius
- Mid Hudson Med Res-New Windsor, New Windsor
- Harlem Cardiology_Madison ave, New York
- in še 3
Vključevanje udeležencevFaza 3
Starost 45 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Brooklyn
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07662109Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- SUNY Upstate Medical Center, Albany
Vključevanje udeležencev
Starost 18–80 · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT07599982APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life
- Weill Cornell Medicine, New York
Vključevanje udeležencev
Starost 18–75 · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT07773779A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- WBMD Pediatrics, Buffalo
- Cohen Children's Medical Center Division of Pediatric Endocrinology, Hyde Park
- SUNY Upstate Medical University, Syracuse
Vključevanje udeležencevFaza 3
Starost 10–17 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06739122Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- The Mount Sinai Hospital, New York
- SUNY Syracuse, Syracuse
Vključevanje udeležencev
Starost 18–75 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT07521475Milk for Diabetes Prevention
- HCHS/SOL Bronx Field Center, The Bronx
Vključevanje udeležencev
Starost 18–70 · Vsi spoli · Posodobljeno 26. maj 2026 · NCT06513026ED Diabetes Screening and Outpatient Care - Aim 3
- NYU Langone Health, New York
Vključevanje udeležencev
Starost 20–70 · Vsi spoli · Posodobljeno 19. maj 2026 · NCT05899023DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- NYU Langone Health- Brooklyn, Brooklyn
- NYU Langone Health- Long Island, Garden City
- NYU Langone Health- Manhattan, New York
- in še 1
Vključevanje udeležencevOpazovalna študija
Starost 8–15 · Vsi spoli · Posodobljeno 7. maj 2026 · NCT06525259Implementing an Effective Diabetes Intervention Among Low-Income Immigrants
- NYU Langone Health, New York
Vključevanje udeležencev
Starost 18–70 · Vsi spoli · Posodobljeno 9. mar. 2026 · NCT06319703High Fructose Diet, the Gut Microbiome, and Metabolic Health
- Mount Sinai Morningside, New York
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 25–45 · Vsi spoli · Posodobljeno 17. dec. 2025 · NCT06329544Effects of HIIT vs. TRE on Type 2 Diabetes Risk
- Syracuse University, Syracuse
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 14–30 · Vsi spoli · Posodobljeno 10. okt. 2025 · NCT07215533Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
- Clindove Research LLC, Brooklyn
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 12. avg. 2025 · NCT07106879NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
Vključevanje udeležencevOpazovalna študija
30 Days · Vsi spoli · Posodobljeno 3. mar. 2025 · NCT06203106RESET System Pivotal Trial (Rev F)
- Weill Cornell Medicine, New York
Vključevanje udeležencev
Starost 22–65 · Vsi spoli · Posodobljeno 18. jul. 2024 · NCT04101669Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
- Brooklyn Clinical Research, Brooklyn
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 11. jun. 2024 · NCT06412536Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.